GT Biopharma Operating Margin Growth & History (GTBP)

GT Biopharma's operating margin was −33,062.96% for fiscal 2015.

View full GT Biopharma company overview

GT Biopharma annual operating margin history

GT Biopharma annual operating margin

Fiscal yearPeriod endedOperating marginChange (percentage points)
20152015-12-31−33,062.96%−29135.09 pp
20142014-12-31−3,927.87%−3712.38 pp
20132013-12-31−215.49%+812.00 pp
20122012-12-31−1,027.49%+14080.21 pp
20112011-12-31−15,107.69%+7592.31 pp
20102010-12-31−22,700.00%

GT Biopharma operating margin trends

Over the last five reported fiscal years, GT Biopharma's operating margin decreased from −22,700.00% to −33,062.96%, a change of −10362.96 percentage points. The latest reported quarter, Q2 2015, shows −7,155.00%.

About the metric

What operating margin means

Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.

Calculation and source

How operating margin is calculated

TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review GT Biopharma filings at SEC.gov ↗